Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2008Cancer ScienceOpen Access

Phase I study of dexamethasone, methotrexate, ifosfamide, l ‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

MYMotoko YamaguchiMie UniversityRSRitsuro SuzukiShimane UniversityYKYok‐Lam KwongQueen Mary Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yamaguchi et al. (2008) studied this question.

synapsesocial.com/papers/6a89917481d3bfa98ef7d128https://doi.org/10.1111/j.1349-7006.2008.00768.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer‐cell neoplasms2005 · 129 citations
  2. 2Revised Response Criteria for Malignant Lymphoma2007 · 4,467 citations
  3. 3In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma‐derived cell line, NK‐YS, by etoposide and cyclosporine A2001 · 36 citations